On December 12, 2020, the National Psoriasis Foundation (NPF) COVID-19 Task Force released updated guidance regarding COVID-19 and psoriatic disease, including new guidance statements on vaccine use for people with psoriasis and/or psoriatic arthritis.
Since that time, NPF has heard many questions from members of our community. We complied questions commonly asked of NPF leadership and staff with questions posed by community members on NPF social media channels and through the Patient Navigation Center to create this brief Q and A video with NPF COVID-19 Task Force co-chair, Dr. Joel Gelfand, M.D., of the University of Pennsylvania Perelman School of Medicine.
%20(27).png?ixlib=gatsbyFP&auto=compress%2Cformat&fit=max&rect=69%2C0%2C600%2C600&w=70&h=70)
%20(26).png?ixlib=gatsbyFP&auto=compress%2Cformat&fit=max&rect=34%2C0%2C300%2C300&w=70&h=70)
